Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 51

1.

Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland.

Debniak T, van de Wetering T, Scott R, Nagay L, Cybulski C, Górski B, Jakubowska A, Gronwald J, Masojć B, Huzarski T, Byrski T, Nej-Wołosiak K, Kładny J, Maleszka R, Lubinski J.

Eur J Cancer Prev. 2008 Oct;17(5):389-91. doi: 10.1097/CEJ.0b013e3282f75eb1.

PMID:
18714178
2.

Genodermatoses with cutaneous tumors and internal malignancies.

Somoano B, Tsao H.

Dermatol Clin. 2008 Jan;26(1):69-87, viii. Review.

PMID:
18023772
3.

Pancreatic cancer and the FAMMM syndrome.

Lynch HT, Fusaro RM, Lynch JF, Brand R.

Fam Cancer. 2008;7(1):103-12. Epub 2007 Nov 9. Review.

PMID:
17992582
4.

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.

Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Melanoma Genetics Consortium (GenoMEL).

Cancer Res. 2006 Oct 15;66(20):9818-28.

5.

Familial pancreatic cancer syndromes.

Habbe N, Langer P, Sina-Frey M, Bartsch DK.

Endocrinol Metab Clin North Am. 2006 Jun;35(2):417-30, xi. Review.

PMID:
16632103
6.

Genotype/phenotype of familial pancreatic cancer.

Brand RE, Lynch HT.

Endocrinol Metab Clin North Am. 2006 Jun;35(2):405-15, xi. Review.

PMID:
16632102
7.

Risk factors associated with earlier age of onset in familial pancreatic carcinoma.

James TA, Sheldon DG, Rajput A, Kuvshinoff BW, Javle MM, Nava HR, Smith JL, Gibbs JF.

Cancer. 2004 Dec 15;101(12):2722-6.

8.

FAMMM syndrome: pathogenesis and management.

Czajkowski R, Placek W, Drewa G, Czajkowska A, Uchańska G.

Dermatol Surg. 2004 Feb;30(2 Pt 2):291-6. Review.

PMID:
14871223
9.

Pancreatic carcinoma surveillance in patients with familial melanoma.

Parker JF, Florell SR, Alexander A, DiSario JA, Shami PJ, Leachman SA.

Arch Dermatol. 2003 Aug;139(8):1019-25.

PMID:
12925390
10.
11.

Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds.

Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA.

Gastroenterology. 2003 May;124(5):1292-9.

PMID:
12730869
12.

Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families.

Måsbäck A, Olsson H, Westerdahl J, Sandberg T, Borg A, Jonsson N, Ingvar C.

Melanoma Res. 2002 Dec;12(6):549-57.

PMID:
12459644
13.

CDKN2A germline mutations in familial pancreatic cancer.

Bartsch DK, Sina-Frey M, Lang S, Wild A, Gerdes B, Barth P, Kress R, Grützmann R, Colombo-Benkmann M, Ziegler A, Hahn SA, Rothmund M, Rieder H.

Ann Surg. 2002 Dec;236(6):730-7.

14.

Screening and surveillance for hereditary pancreatic cancer.

Kimmey MB, Bronner MP, Byrd DR, Brentnall TA.

Gastrointest Endosc. 2002 Oct;56(4 Suppl):S82-6. No abstract available.

PMID:
12297755
15.
16.

Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer.

Hruban RH, Canto MI, Yeo CJ.

Dig Dis. 2001;19(1):76-84. Review.

PMID:
11385254
17.

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).

Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W.

Int J Cancer. 2000 Sep 15;87(6):809-11.

18.

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, Westerdahl J, Olsson H, Ingvar C.

J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6.

PMID:
10922411
19.

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA.

J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10.

PMID:
10861313
20.

Melanoma screening: report of a survey in occupational medicine.

Guibert P, Mollat F, Ligen M, Dreno B.

Arch Dermatol. 2000 Feb;136(2):199-202.

PMID:
10677096

Supplemental Content

Support Center